Anchorage Capital Group, L.L.C. Roivant Sciences Ltd. Transaction History
Anchorage Capital Group, L.L.C.
- $255 Million
- Q4 2024
A detailed history of Anchorage Capital Group, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Anchorage Capital Group, L.L.C. holds 4,832,642 shares of ROIV stock, worth $51.7 Million. This represents 22.39% of its overall portfolio holdings.
Number of Shares
4,832,642
Previous 4,832,642
-0.0%
Holding current value
$51.7 Million
Previous $55.8 Million
2.51%
% of portfolio
22.39%
Previous 15.47%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$704 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$664 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$512 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$378 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.54B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...